相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。α-Methyltryptamine (α-MT) Metabolite Profiling in Human Hepatocyte Incubations and Postmortem Urine and Blood
Sara Malaca et al.
METABOLITES (2023)
Pharmacokinetics of N,N-dimethyltryptamine in Humans
Meghan Good et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2023)
Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants
Severin B. B. Vogt et al.
TRANSLATIONAL PSYCHIATRY (2023)
Development and application of a highly sensitive LC-MS/MS method for simultaneous quantification of N,N-dimethyltryptamine and two of its metabolites in human plasma
Emma Eckernas et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2022)
Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder
Deepak Cyril D'Souza et al.
NEUROPSYCHOPHARMACOLOGY (2022)
Liquid chromatography-tandem mass spectrometry method for the bioanalysis of N,N-dimethyltryptamine (DMT) and its metabolites DMT-N-oxide and indole-3-acetic acid in human plasma
Dino Luethi et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2022)
Studies on the In Vitro and In Vivo Metabolic Fate of the New Psychoactive Substance N-Ethyl-N-Propyltryptamine for Analytical Purposes
Sascha K. Manier et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2021)
A Review of the Important Role of CYP2D6 in Pharmacogenomics
Christopher Taylor et al.
GENES (2020)
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
Fernanda Palhano-Fontes et al.
PSYCHOLOGICAL MEDICINE (2019)
Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MSn, and LC-HR-MS/MS
Achim T. Caspar et al.
DRUG TESTING AND ANALYSIS (2018)
Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MSn, and LC-HR-MS/MS
Julian A. Michely et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2017)
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression A SPECT Study
Rafael Faria Sanches et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MS n , and LC-HR-MS-MS
Julian A. Michely et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2015)
Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study
Jordi Riba et al.
DRUG TESTING AND ANALYSIS (2015)
Biosynthesis of N,N-dimethyltryptamine (DMT) in a melanoma cell line and its metabolization by peroxidases
Melissa M. Gomes et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Methodology for determining major constituents of ayahuasca and their metabolites in blood
Ethan H. McIlhenny et al.
BIOMEDICAL CHROMATOGRAPHY (2012)
Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca
Jordi Riba et al.
DRUG TESTING AND ANALYSIS (2012)
Inhibition of Human Cytochrome P450 Enzymes 3A4 and 2D6 by β-Carboline Alkaloids, Harmine Derivatives
Ting Zhao et al.
PHYTOTHERAPY RESEARCH (2011)
Metabolism of the psychotomimetic tryptamine derivative 5-methoxyn, N,N-diisopropyltryptamine in humans:: Identification and quantification of its urinary metabolites
T Kamata et al.
DRUG METABOLISM AND DISPOSITION (2006)